CME CBI Med Ed Forum March 21-22 Offers Insight on Improving Outcomes and… Thomas Sullivan Feb 9, 2011 0 The Center for Business Intelligence (CBI) will be holding a Medical Education Forum entitled, “Improve Outcomes through…
CME A Decrease in CME Support Equals Less Innovation Thomas Sullivan Feb 9, 2011 1 In response to an article we posted last fall about the continued criticism of industry funded continuing medical education…
Media NY Times Magazine: A Prescription for Fear Thomas Sullivan Feb 8, 2011 1 Over the past several years, the internet has constantly and consistently changed the face of healthcare, and many would argue,…
Media Panic Virus: Deciding the Truth Thomas Sullivan Feb 7, 2011 0 Last year, the journal Lancet retracted a1998 study linking a routine childhood vaccine to autism and bowel disease after a U.K.…
HHS-OIG HHS OIG: Institutional Conflicts of Interests at NIH Grantees Thomas Sullivan Feb 4, 2011 0 The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services (HHS), is the nation’s medical…
Congress Shortage of Injection Treatments Looms over ACA Thomas Sullivan Feb 3, 2011 0 As the Obama Administration and federal agencies begin preparing for implementation of key provisions of the Affordable Care Act…
FDA Risk Evaluation and Mitigation Strategies (REMS) Summary Thomas Sullivan Feb 3, 2011 0 According to a recent assessment by the Tufts Center for the Study of Drug Development (CSDD), “drug developers, healthcare…
Executive Branch IRS Releases Proposed ACA Fee Structure for Pharmaceutical Medical Device… Thomas Sullivan Feb 2, 2011 0 With implementation of the new device tax two years away, the Internal Revenue Service (IRS) is trying to determine which devices…
Academic Organizations University of Miami Business Forum: The Business of Healthcare –… Thomas Sullivan Feb 1, 2011 0 The University of Miami Schools of Business and Medicine held the University of Miami Global Business Forum. The event, entitled…
Events FDA Boot Camp — Hooah Thomas Sullivan Feb 1, 2011 1 As the regulatory landscape for pharmaceutical and medical device companies continues to rapidly change, and as key provisions of…